EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Noonan syndrome caused by a pathogenic SOS1 variant: expanding the phenotypic spectrum and molecular correlations

Laura María Zabala Sepúlveda, Lina Johanna Moreno Giraldo

Journal of Biochemical and Clinical Genetics · 2025

DOI: 10.24911/jbcgenetics.11-2290 ↗
AbstractBibliografische Angaben

Abstract

Background: Noonan syndrome (NS) is an autosomal dominant condition characterized by facial dysmorphism, congenital heart disease, growth impairment, and ectodermal findings. Variants in SOS1 account for a large proportion of cases.

Case presentation: We report a male infant with nasal bone hypoplasia and shortening of long bones identified during the prenatal period. After birth, he presented with facial dysmorphism, pulmonary valve stenosis, axial hypotonia, and renal anomalies. The karyotype was normal. Whole-exome sequencing with CNV analysis focused on NS-related genes identified a heterozygous SOS1 variant, c.1656G>T (p.Arg552Ser), classified as pathogenic according to ACMG criteria and curated databases, supporting the diagnosis of SOS1-related Noonan syndrome type 4. The SOS1 p.Arg552Ser variant has been reported in individuals with typical NS features, supporting the genotype–phenotype correlation. In this patient, the combination of prenatal skeletal markers and postnatal renal involvement illustrates the wide phenotypic variability. Early molecular confirmation allowed multidisciplinary care and targeted surveillance (cardiac, endocrine, and oncologic), as well as genetic counseling.

Conclusion: This case highlights the diagnostic utility of early exome sequencing when NS is suspected, but

the phenotype is incomplete, and emphasizes the value of integrating prenatal markers with postnatal findings to enable timely management guided by precision medicine.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →